Filter
1055
Text search:
antibodies
Featured
Recommendations
135
New Publications
268
Language
Document type
No document type
528
Guidelines
223
Studies & Reports
129
Manuals
57
Fact sheets
52
Strategic & Response Plan
23
Training Material
17
Situation Updates
9
Brochures
5
Resource Platforms
5
Videos
4
Infographics
2
App
1
Countries / Regions
India
85
Global
51
Nepal
21
Nigeria
20
South Africa
20
Latin America and the Carribbean
20
Tanzania
17
Philippines
15
Africa
14
Middle East and North Africa
13
Germany
12
Russia
12
Liberia
11
Ethiopia
11
Kenya
11
Brazil
11
Sierra Leone
10
Syria
10
Malawi
10
East and Southern Africa
10
West and Central Africa
10
Western and Central Europe
10
Uganda
9
Zambia
8
Rwanda
8
Eastern Europe
7
Congo, Democratic Republic of
6
Namibia
6
Venezuela
6
Ukraine
5
Colombia
5
Myanmar / Burma
5
Yemen
5
Guinea
4
Burkina Faso
4
Indonesia
4
Peru
4
Mali
3
USA
3
Saudi Arabia
3
Cameroon
3
Zimbabwe
3
Pakistan
3
South Sudan
3
Afghanistan
3
Lebanon
3
Turkey
3
Bangladesh
3
Ecuador
3
Lesotho
3
South–East Asia Region
3
Asia
3
Spain
3
Senegal
2
Côte d’Ivoire / Ivory Coast
2
Ghana
2
Niger
2
Haiti
2
Somalia
2
Iraq
2
Jordan
2
Egypt
2
Chad
2
Cambodia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Botswana
2
Bolivia
2
Libya
2
Madagascar
2
Mexico
2
Paraguay
2
Qatar
2
Georgia
2
Vietnam
2
France
2
United Kingdom
2
Morocco
1
Mauritania
1
Papua New Guinea
1
Benin
1
Argentina
1
Dominican Republic
1
North Macedonia
1
Serbia
1
Cuba
1
Honduras
1
El Salvador
1
Angola
1
Guatemala
1
Nicaragua
1
Chile
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Tajikistan
1
Moldova
1
Iran
1
Uzbekistan
1
Kazakhstan
1
North America
1
Jamaica
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
332
Clinical Guidelines
169
Public Health
45
Pharmacy & Technologies
40
Women & Child Health
39
Capacity Building
20
Key Resources
13
Toolboxes
COVID-19
198
HIV
115
NTDs
86
Rapid Response
63
Ebola
44
Zika
35
TB
32
Refugee
23
Pharmacy
19
Mental Health
18
NCDs
18
Planetary Health
13
Polio
12
AMR
11
Caregiver
11
Cholera
6
Natural Hazards
4
Conflict
3
Health Financing Toolbox
3
Disability
2
Specific Hazards
1
Global Health Education
1
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp
...
Malgré les progrès récents vers la mise au point d’un traitement hautement efficace et abordable contre le virus de l’hépatite C, beaucoup de personnes infectées par ce virus ne connaissent pas leur statut. L’Organisation mondiale de la Santé (OMS) estime qu’en 2019, 58 millions
...
As a high-burden neglected tropical disease, soil-transmitted helminth (STH) infections remain a major problem in the world, especially among children under five years of age. Since young children are at high risk of being infected, STH infection can have a long-term negative impact on their life, i
...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th
...
Organización Mundial de la Salud. (2022). Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [recombinante] (Convidecia™) contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health issue due to its high case fatality rate.
...
Diagnosis, Case Management Prevention and Control of Leptospirosis
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products
...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p
...
Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria. This analysis overviews landscape analyses of point-of-care diagnostic technologies for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vagi
...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP
...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog
...
Cholera remains a significant public health threat in many countries worldwide. In resource-constrained settings, it disproportionately affects thousands of poor and vulnerable population
Case definitions, clinical classification, and disease phases Dengue, Chikungunya, and Zika
recommended
A person who lives in or has traveled in the previous 14 days to areas with dengue transmission, and presents with acute fever that has typically lasted 2 to 7 days, and two or more of the following clinical manifestations: nausea or vomiting, exanthema, headache or retro-orbital pain, myalgia or ar
...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors.
...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
